Evidence map›Paper›PMID 18385757›Full record

ArticleThe Journal of investigative dermatology2008

Activation of keratinocyte protein kinase C zeta in psoriasis plaques.

Yuming Zhao, Rita Fishelevich, John P Petrali, Lida Zheng, Malinina Alla Anatolievna, April Deng, Richard L Eckert, Anthony A Gaspari

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of investigative dermatology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Yuming ZhaoDepartment of Dermatology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
Rita Fishelevich
John P Petrali
Lida Zheng
Malinina Alla Anatolievna
April Deng
Richard L Eckert
Anthony A Gaspari
University of Maryland, Baltimore · US

Funding

Polycomb proteins and skin cancer preventionR01CA131074 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI ECKERT, RICHARD L. · 2008 to 2017
$4.6M
Polycomb genes and keratinocyte functionR01AR053851 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI ECKERT, RICHARD L. · 2008 to 2012
$2.2M
IRRITANTS EFFECTS ON EPIDERMAL ANTIGEN PRESENTATIONR01AR046108 · NIAMS · UNIVERSITY OF ROCHESTER · PI GASPARI, ANTHONY A · 1998 to 2002
$813k
NCI NIH HHS R01 CA131074NIAMS NIH HHS R01 AR053851NIAMS NIH HHS R01-AR46108-05
6 · The paper itself

Abstract

PKCzeta (protein kinase C-zeta), a member of protein kinase C family, plays an important role in cell proliferation, differentiation, and apoptosis. It acts as a downstream molecule for TNF-alpha (tumor necrosis factor) signal transduction and also regulates the expression of CD1d, an HLA-class I-like molecule. The interaction of CD1d with natural killer T (NKT) cells has been shown to be important in their Th1 cytokine production in psoriasis. In this study, we examined PKCzeta in psoriasis in order to define its role in the pathogenesis of the disease. We found that T-cell receptor (TCR) V alpha24+ V beta11+ NKT cells and CD1d molecules within psoriatic skin were increased. Moreover, there was an associated increase in PKCzeta mRNA and protein expression with membrane translocation in psoriasis lesions compared to uninvolved skin. Furthermore, cultured keratinocytes exhibited increased PKCzeta activity and membrane translocation upon stimulation by TNF-alpha, a cytokine known to play an important role in the pathogenesis of psoriasis. These results implied that PKCzeta is an important transduction molecule downstream of TNF-alpha signaling and is associated with increased expression of CD1d that may enhance CD1d-NKT cell interactions in psoriasis lesions. This makes PKCzeta a tempting target for possible pharmacological intervention in modifying the downstream effects of TNF-alpha in psoriasis.

Indexed as

Antigens, CD1Antigens, CD1dCell LineCells, CulturedEnzyme ActivationHumansKeratinocytesKiller Cells, NaturalMaleProtein Kinase CProtein Kinase C zetaPsoriasisReceptors, Antigen, T-CellRNA, MessengerSignal TransductionTumor Necrosis Factor-alphaAntigens, CD1Antigens, CD1dCD1D protein, humanProtein Kinase CProtein Kinase C zetaReceptors, Antigen, T-CellRNA, MessengerTumor Necrosis Factor-alpha

Identifiers

PMID18385757
PMCPMC3120228
OpenAlexW1996819049

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.